Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Objective: This study used machine learning techniques combined with peripheral biomarker measurements to build signatures to help differentiating (1) patients with bipolar depression from patients with unipolar depression, and (2) patients with bipolar depression or unipolar depression from healthy controls. Methods: We assessed serum levels of interleukin-2, interleukin-4, interleukin-6, interleukin-10, tumor necrosis factor-α, interferon-γ, interleukin-17A, brain-derived neurotrophic factor, lipid peroxidation and oxidative protein damage in 54 outpatients with bipolar depression, 54 outpatients with unipolar depression and 54 healthy controls, matched by sex and age. Depressive symptoms were assessed using the Hamilton Depression Rating Scale. Variable selection was performed with recursive feature elimination with a linear support vector machine kernel, and the leave-one-out cross-validation method was used to test and validate our model. Results: Bipolar vs unipolar depression classification achieved an area under the receiver operating characteristics (ROC) curve (AUC) of 0.69, with 0.62 sensitivity and 0.66 specificity using three selected biomarkers (interleukin-4, thiobarbituric acid reactive substances and interleukin-10). For the comparison of bipolar depression vs healthy controls, the model retained five variables (interleukin-6, interleukin-4, thiobarbituric acid reactive substances, carbonyl and interleukin-17A), with an AUC of 0.70, 0.62 sensitivity and 0.7 specificity. Finally, unipolar depression vs healthy controls comparison retained seven variables (interleukin-6, Carbonyl, brain-derived neurotrophic factor, interleukin-10, interleukin-17A, interleukin-4 and tumor necrosis factor-α), with an AUC of 0.74, a sensitivity of 0.68 and 0.70 specificity. Conclusion: Our findings show the potential of machine learning models to aid in clinical practice, leading to more objective assessment. Future studies will examine the possibility of combining peripheral blood biomarker data with other biological data to develop more accurate signatures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An analysis of variance test for normality (complete samples)
SHAPIRO, S. S., & WILK, M. B. (1965) · Biometrika · doi:10.1093/biomet/52.3-4.591 · Cited by 23,480
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627 · cited 1×
“Bipolar disorder (BD) and major depressive disorder (MDD) are among the main contributors to the global burden of diseases (Collins et al., 2011; World Health Organization [WHO], 2017), with a prevalence of 2.4% and 16.2% worldwide, respectively (Merikangas et al., 2011; Kupfer et al., 2012).”
BackgroundInfluentialGrand challenges in global mental health
Collins, P. Y., Patel, V., Joestl, S. S., March, D., Insel, T. R., Daar, A. S., Bordin, I. A., Costello, E. J., Durkin, M., Fairburn, C., et al. (2011) · Nature · doi:10.1038/475027a · Cited by 2,043 · cited 1×
“Bipolar disorder (BD) and major depressive disorder (MDD) are among the main contributors to the global burden of diseases (Collins et al., 2011; World Health Organization [WHO], 2017), with a prevalence of 2.4% and 16.2% worldwide, respectively (Merikangas et al., 2011; Kupfer et al., 2012).”
BackgroundInfluentialPeripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · cited 8×
“Immune abnormalities are associated with the pathophysiology of chronic psychiatric disorders including unipolar depression (Köhler et al., 2017) and BD (Brietzke et al.”
BackgroundMethodResultInfluentialSeverity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199 · cited 1×
“Depressive symptoms were evaluated using the Hamilton Depression Rating Scale (HDRS; Hamilton, 1960), where patients with a score higher than seven were considered in a depressive episode (Zimmerman et al., 2013).”
MethodBerk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Self-citationMajor depressive disorder: new clinical, neurobiological, and treatment perspectives
Kupfer, D. J., Frank, E., & Phillips, M. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60602-8 · Cited by 894 · cited 1×
“Bipolar disorder (BD) and major depressive disorder (MDD) are among the main contributors to the global burden of diseases (Collins et al., 2011; World Health Organization [WHO], 2017), with a prevalence of 2.4% and 16.2% worldwide, respectively (Merikangas et al., 2011; Kupfer et al., 2012).”
BackgroundInfluentialIs depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
Inflamed moods: A review of the interactions between inflammation and mood disorders
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.013 · Cited by 609 · cited 4×
“…the content of lipid peroxidation by TBARS assay and oxidative damage to proteins assessed by carbonyl levels), that were selected according to previous knowledge in the field (Black et al., 2015; Köhler et al., 2017; Modabbernia et al., 2013; Pfaffenseller et al., 2013; Rosenblat et al., 2014).”
BackgroundMethodInfluentialCytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596
Cited by
Dionisie, V., Filip, G. A., Manea, M. C., Movileanu, R. C., Moisa, E., Manea, M., Riga, S., & Ciobanu, A. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091924 · Cited by 82
Richter, T., Fishbain, B., Richter-Levin, G., & Okon-Singer, H. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11100957 · Cited by 52
Hursitoglu, O., Kurutas, E. B., Strawbridge, R., Oner, E., Gungor, M., Tuman, T. C., & Uygur, O. F. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110670 · Cited by 18
(2023) · doi:10.1038/s44184-023-00024-z · Cited by 12
(2022) · doi:10.1101/2022.04.26.22274241 · Cited by 12
Metadata
- Authors
- Wollenhaupt-Aguiar, B., Librenza-Garcia, D., Bristot, G., Przybylski, L., Stertz, L., Kubiachi Burque, R., Ceresér, K. M., Spanemberg, L., Caldieraro, M. A., Frey, B. N., Fleck, M. P., Kauer-Sant’Anna, M., Passos, I. C., & Kapczinski, F.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2019-12-02
- Volume
- 54
- Issue
- 4
- Pages
- 393-401
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2990932459
- Cited by
- 68
- References
- 19
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach. https://app.cochat.ai/papers/10.1177/0004867419888027
- The paper
- Wollenhaupt-Aguiar, B., Librenza-Garcia, D., Bristot, G., Przybylski, L., Stertz, L., Kubiachi Burque, R., Ceresér, K. M., Spanemberg, L., Caldieraro, M. A., Frey, B. N., Fleck, M. P., Kauer-Sant’Anna, M., Passos, I. C., & Kapczinski, F. (2020). Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867419888027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.